PEAK6 Group’s ResMed RMD Stock Holding History

PEAK6 Group’s Portfolio RMD Stock Details RMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	$5.49M	Buy	53,000 +52,900	+52,900%	+$5.35M	0.02%	720
2018 Q1	$10K	Buy	+100	New	+$9.45K	﹤0.01%	4177
2017 Q4	–	Sell	-5,200	Closed	-$400K	–	4681
2017 Q3	$400K	Buy	5,200 +3,600	+225%	+$275K	﹤0.01%	2718
2017 Q2	$125K	Buy	+1,600	New	+$114K	﹤0.01%	3714
2017 Q1	–	Sell	-1,700	Closed	-$105K	–	4874
2016 Q4	$105K	Hold	1,700	–	–	﹤0.01%	3841
2016 Q3	$110K	Sell	1,700 -1,900	-53%	-$126K	﹤0.01%	3528
2016 Q2	$228K	Buy	+3,600	New	+$212K	﹤0.01%	3046
2016 Q1	–	Sell	-3,800	Closed	-$204K	–	4952
2015 Q4	$204K	Buy	+3,800	New	+$214K	﹤0.01%	3436
2015 Q1	–	Sell	-15,000	Closed	-$841K	–	5175
2014 Q4	$841K	Hold	15,000	–	–	0.01%	2103
2014 Q3	$739K	Buy	+15,000	New	+$764K	0.01%	2107
2013 Q4	–	Sell	-83,600	Closed	-$2.21M	–	5363
2013 Q3	$2.21M	Buy	83,600 +72,800	+674%	+$3.53M	0.02%	1451
2013 Q2	$487	Buy	+10,800	New	+$512K	﹤0.01%	2817

Other funds holding RMD

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

PEAK6 Group's RMD Position: Q2 2018 in Review

PEAK6 Group increased its ResMed (RMD) stake by 19% in Q2 2018, buying an estimated $77.1K and bringing the position to 4,807 shares worth $498K. The position accounts for ﹤0.01% of the portfolio, ranked #2598.

PEAK6 Group first reported a position in RMD in Q3 2013 and has held it in 5 quarters since. The position peaked at $981K in Q4 2016. 465 funds tracked by Wall St. Rank hold RMD as of Q2 2018.

PEAK6 Group held 4,807 shares of ResMed worth $498K as of Q2 2018.
PEAK6 Group bought 762 ResMed shares in Q2 2018, an estimated $77.1K.
ResMed made up ﹤0.01% of PEAK6 Group's portfolio in Q2 2018, its #2598 holding.
PEAK6 Group first reported a position in ResMed in Q3 2013 and has held it in 5 quarters since.
PEAK6 Group's ResMed position peaked at $981K in Q4 2016.
465 funds tracked by Wall St. Rank held ResMed as of Q2 2018.

Based on PEAK6 Group's 13F filing for Q2 2018, filed 15 Aug 2018.